Top 10 Medical Stocks To Invest In 2017


We listened to Cempra (NASDAQ: CEMP) management’s investor conference call after receiving the Complete Response Letter (CRL) from the FDA regarding regulatory application for Solithromycin’s approval for the treatment of adult community-acquired bacterial pneumonia (CABP). The management plans to meet with the FDA to discuss FDA’s request for a comparative safety trial to study possible hepatotoxicity of Solithromycin. On reviewing the medical literature (source), we believe that the idiosyncratic liver toxicity seen with prolonged Telithromycin use may be related to blockade of 伪-7 nicotinic acetylcholine receptors (due to decreased vagal activity caused by pyridine piece of Telithromycin. This pyridine piece is also believed to be behind other side effects like worsening of myasthenia gravis seen with Telithromycin.


Solithromycin does not have this pyridine piece in aryl-alkyl side chain and does not significantly block 伪-7 nicotinic acetylcholine receptors. Mi ld elevation in liver enzymes seen with Solithromycin in previous clinical trials is a class effect of macrolides, and was clinically insignificant and reversible after stopping therapy. The overcautious stance of FDA seems to be due to its previous bad experience with serious side effects seen with prolonged Telithromycin use after approval (with even few deaths). Although Solithromycin is a first-in-class fluoroketolide macrolide, FDA seems to be taking an overcautious approach due to it being another ketolide macrolide antibiotic (Telithromycin is a ketolide macrolide).

Top 10 Medical Stocks To Invest In 2017: Deutsche Bank AG(DB)


Advisors’ Opinion:

  • [By Diane Alter]

    The New York Times first reported that Frontier Airlines is prepping for an initial public offering. The Denver, Colo.-based low-cost carrier has hired Deutsch Bank (NYSE: DB), JPMorgan Chase & Co. (NYSE: JPM), and Evercore Partners Inc. (NYSE: EVR) to handle the IPO. The airline started the process late last year when it approached a number of bankers.

  • [By WWW.THESTREET.COM]

    Today, Deutsche Bank (DB) pretty much signals an all-clear based on that call and says things are indeed getting better. So there are buyers all over the place.

Top 10 Medical Stocks To Invest In 2017: ADA-ES Inc.(ADES)


Advisors’ Opinion:

  • [By Jim Robertson]

    Yesterday, our Under the Radar Moversnewsletter suggested small cap emissions solutions stock Advanced Emissions Solutions, Inc (NASDAQ: ADES) as a potential long/bullish trade:

Top 10 Medical Stocks To Invest In 2017: Gartner, Inc.(IT)

Advisors’ Opinion:

  • [By Lisa Levin]

    CEB Inc. (NYSE: CEB) shares were also up, gaining 21 percent to $74.90 after Gartner Inc (NYSE: IT) announced plans to acquire the company for $2.6 billion in cash and stock.

Top 10 Medical Stocks To Invest In 2017: Fiat Chrysler Automobiles N.V.(FCAM)


Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    The showstopper by far in the early going is Waymo’s self-driving minivan (pictured below) in partnership with Fiat Chrysler (FCAM) . Waymo’s ultimate mom-mobile, coming from a business that was spun-off from Google’s parent company Alphabet Inc. (GOOG) last month, is equipped with self-driving sensors and vision systems.

Top 10 Medical Stocks To Invest In 2017: PACCAR Inc.(PCAR)


Advisors’ Opinion:

  • [By JPMorgan]

    We are Neutral on PCAR as the company faces the risk of both lower volume and margin pressure from declining demand in its core NA HD truck business in 2016. However, we believe PCAR should command a premium valuation due to its track record of solid execution. In addition, PCAR pays out a normal and a special dividend which, in total, should equal ~50% of net income and currently offers a yield of 4.1% (JPMe total payout of ~$2.12/share) making it potentially attractive to income-oriented investors. 

  • [By Jim Cramer]

    The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Machinery industry. The net income increased by 16.1% when compared to the same quarter one year prior, going from $371.40 million to $431.20 million.

     

  • [By Jim Cramer]

    Despite the weak revenue results, PCAR has outperformed against the industry average of 21.6%. Since the same quarter one year prior, revenues slightly dropped by 1.6%. The declining revenue has not hurt the company’s bottom line, with increasing earnings per share.


     

  • [By Jim Cramer]

    The return on equity has improved slightly when compared to the same quarter one year prior. This can be construed as a modest strength in the organization. Compared to other companies in the Machinery industry and the overall market, PACCAR INC’s return on equity exceeds that of both the industry average and the S&P 500.

     

Top 10 Medical Stocks To Invest In 2017: HSBC Holdings plc(HSBC)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Up first on our list of financial sector breakout trades is $156 billion global bank HSBC Holdings plc (HSBC) . Don’t get fooled by the headline numbers in HSBC this year – shares may be hovering around breakeven year-to-date, but they’re up more than 35% from their April lows. And after tracking sideways for the last couple of months, HSBC is back in breakout mode this week.

Top 10 Medical Stocks To Invest In 2017: Nucor Corporation(NUE)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Then there are the steel plays. United States Steel Corp. (NYSE: X) was up 7.4% at $27.61 late on Monday. It has a market cap of $4.5 billion. Over the past five trading days the stock has gained 30%. Nucor Corp. (NYSE: NUE) was last seen up 1% at $59.34. Nucor has a total market cap of $18.8 billion. Over the past fivetrading days the stock has gained 17%.

  • [By Ben Levisohn]

    There’s been a lot of talk that the revival of the Keystone XL pipeline–and the possibility of other pipelines as well–could boost the shares of steel makers like U.S. Steel (X), AK Steel (AKS), Nucor (NUE) and Steel Dynamics (STLD). Axiom Capital’s Gordon Johnson disagrees:

Top 10 Medical Stocks To Invest In 2017: Neometals Ltd (RRSSF)


Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

Top 10 Medical Stocks To Invest In 2017: Identiv, Inc.(INVE)


Advisors’ Opinion:

  • [By Lisa Levin]

    The industries that are driving the market today are:

    Cement: This industry gained 3.4 percent by 2:30 pm. The top stock within the industry was Cemex SAB de CV (ADR) (NYSE: CX), which gained 4.7 percent. Cemex’s PEG ratio is 0.16. Computer Peripherals: This industry rose 2.6 percent by 2:30 pm ET. The top performer in this industry was Identiv Inc (NASDAQ: INVE), which gained 13.5 percent. Identiv shares have climbed 44.83 percent over the past 52 weeks, while the S&P 500 index has increased 8.61 percent in the same period. Internet Service Providers: The industry gained 2 percent by 2:30 pm. The top performer in this industry was TrueCar Inc (NASDAQ: TRUE) which gained 3.4 percent. TrueCar shares have jumped 60.90 percent over the past 52 weeks, while the S&P 500 index has increased 8.61 percent in the same period. Regional – Southwest Banks: This industry moved up 1.9 percent by 2:30 pm. The top performer in this industry was Veritex Holdings Inc (NASDAQ: VBTX), which rose 6.6 percent

Top 10 Medical Stocks To Invest In 2017: SVB Financial Group(SIVB)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    SVB Financial Group (NASDAQ: SIVB) has a Buy rating at the firm, and this top pick among the bank stocks has a price objective of $190 versus a current $170.38 close. The parent of Silicon Valley Bank has a consensus analyst price target of $176.19, and its 52-week range is $77.87 to $176.77.

Leave a Reply

Your email address will not be published. Required fields are marked *